The long range goal is to develop new strategies for the treatment of HIV-disease based on intra-cellular immunization delivered via retrovirus vectors. However, current murine retrovirus-based systems have for the most part failed to transduce primary human cells with the efficiency needed to successfully cure a genetic or infectious disease. In addition they are limited by their inability to infect non-dividing cells. This has been a significant hindrance for the transduction of human hematopoietic stem/early progenitor cells. Lentiviruses such as HIV are able to infect some non-dividing terminally differentiated cells. In addition HIV efficiently infects primary human CD4+ cells. In this application, the investigator proposes to harness the ability of HIV to infect primary human cells and establish a packaging system for gene transfer and gene therapy (Specific Aim 1). In order to expand the tropism of this producer line beyond that of HIV, he will incorporate heterologous envelope genes which have been shown to infect a variety of tissues and species. In addition, he will develop retrovirus vectors to be used with the HIV-based producer line (Specific Aim 2). This strategy at a minimum will complement and expand the currently available murine-based retroviral gene transfer systems and optimally has the potential to facilitate the implementation of human gene therapy protocols for the treatment of HIV disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI039416-03
Application #
2672695
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1996-09-01
Project End
1999-02-28
Budget Start
1998-09-01
Budget End
1999-02-28
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Smith, M Shane; Goldman, Devorah C; Bailey, Alexis S et al. (2010) Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8:284-91
Wege, A K; Melkus, M W; Denton, P W et al. (2008) Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 324:149-65
Denton, Paul W; Estes, Jacob D; Sun, Zhifeng et al. (2008) Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 5:e16
Sun, Zhifeng; Denton, Paul W; Estes, Jacob D et al. (2007) Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 204:705-14
Melkus, Michael W; Estes, Jacob D; Padgett-Thomas, Angela et al. (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316-22
Gatlin, Joel; Islas-Ohlmayer, Miguel; Garcia, J Victor (2003) Detection and titration of lentivirus vector preparations. Methods Mol Biol 229:57-68
Palucka, A Karolina; Gatlin, Joel; Blanck, Jean Philippe et al. (2003) Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 102:3302-10
Hamra, F Kent; Gatlin, Joel; Chapman, Karen M et al. (2002) Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci U S A 99:14931-6
Wilund, Kenneth R; Yi, Ming; Campagna, Filomena et al. (2002) Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet 11:3019-30
Gatlin, J; Unett, D J; Lerner, M R et al. (2001) Efficient, long-term transgene expression in Xenopus laevis dermal melanophores. Pigment Cell Res 14:275-82

Showing the most recent 10 out of 21 publications